Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-002715
Filing Date
2021-03-10
Accepted
2021-03-10 16:31:03
Documents
105
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ptgx-20201231x10k.htm   iXBRL 10-K 2705287
2 EX-4.7 ptgx-20201231xex4d7.htm EX-4.7 20204
3 EX-21.1 ptgx-20201231xex21d1.htm EX-21.1 3537
4 EX-23.1 ptgx-20201231xex23d1.htm EX-23.1 3317
5 EX-23.2 ptgx-20201231xex23d2.htm EX-23.2 2863
6 EX-31.1 ptgx-20201231xex31d1.htm EX-31.1 11394
7 EX-31.2 ptgx-20201231xex31d2.htm EX-31.2 11360
8 EX-32.1 ptgx-20201231xex32d1.htm EX-32.1 10292
9 GRAPHIC ptgx-20201231x10k006.jpg GRAPHIC 56488
10 GRAPHIC ptgx-20201231x10k007.jpg GRAPHIC 43092
11 GRAPHIC ptgx-20201231x10k008.jpg GRAPHIC 30472
12 GRAPHIC ptgx-20201231x10k009.jpg GRAPHIC 37799
13 GRAPHIC ptgx-20201231x10k010.jpg GRAPHIC 45063
14 GRAPHIC ptgx-20201231x10k011.jpg GRAPHIC 44936
15 GRAPHIC ptgx-20201231x10k012.jpg GRAPHIC 48512
16 GRAPHIC ptgx-20201231x10k013.jpg GRAPHIC 15664
  Complete submission text file 0001558370-21-002715.txt   11515298

Data Files

Seq Description Document Type Size
17 EX-101.SCH ptgx-20201231.xsd EX-101.SCH 76088
18 EX-101.CAL ptgx-20201231_cal.xml EX-101.CAL 80153
19 EX-101.DEF ptgx-20201231_def.xml EX-101.DEF 252637
20 EX-101.LAB ptgx-20201231_lab.xml EX-101.LAB 611153
21 EX-101.PRE ptgx-20201231_pre.xml EX-101.PRE 509855
22 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20201231x10k_htm.xml XML 1948394
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37852 | Film No.: 21730186
SIC: 2834 Pharmaceutical Preparations